6/23/2026

Ifosfamide Injection

Products Affected - Description

- IFEX powder for solution for injection, Baxter, 1 gram, vial, 1 count, NDC 00338-3991-01
- IFEX powder for solution for injection, Baxter, 3 gram, vial, 1 count, NDC 00338-3993-01
- Ifosfamide powder for solution for injection, Baxter, 1 gram, vial, 1 count, NDC 10019-0925-01
- Ifosfamide powder for solution for injection, Baxter, 3 gram, vial, 1 count, NDC 10019-0926-02
- Ifosfamide lyophilized powder for injection, Fresenius Kabi, 1 gram, vial, 1 count, NDC 63323-0142-10
- Ifosfamide injection, Hikma, 50 mg/mL, 20 mL vial, NDC 00143-9531-01
- Ifosfamide injection, Hikma, 50 mg/mL, 60 mL vial, NDC 00143-9530-01

Reason for the Shortage

- Baxter has ifosfamide injection on shortage due to manufacturing delays.
- Fresenius Kabi has ifosfamide injection on shortage due to increased demand.
- Hikma has ifosfamide injection on shortage due to increased demand.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Fresenius Kabi has ifosfamide 1 gram vials on back order and the company estimates a release date of mid-August 2026.
- Hikma has ifosfamide 50 mg/mL 20 mL vials on allocation. The 60 mL vials are on back order and the company estimates a release date of mid-July 2026.
- Baxter has 1 gram vials on a limited allocation. The 3 gram vials are on back order with an estimated release date of late-August 2026.
- Baxter has IFEX 1 gram vials on a limited allocation. The 3 gram vials are on back order and the company estimates a release date of October 2026.

Updated

Updated June 23, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 17, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2026, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.